Peritoneal Dialysis-associated Peritonitis
13
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
7.7%
1 terminated out of 13 trials
85.7%
-0.8% vs benchmark
31%
4 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Prevention of Peritonitis in Peritoneal Dialysis
Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis
Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis
Clinical Trial on Antibiotic-Lock in Tenckhoff Catheter for Relasping and Repeat Peritonitis
In Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath Device
A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis
A Prospective Clinical Study of the CloudCath System During In-home Peritoneal Dialysis
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) Clinical Trial Protocol
Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter.
Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis
The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis
Defining the Optimal Duration of Treatment for "Low-Risk" Peritoneal Dialysis-Related Peritonitis
Improved Diagnosis of Peritoneal Dialysis Peritonitis by Calorimetry